TASVAX HUIT
TASVAX HUIT
Mhux awtorizzat
- Clostridium chauvoei, strain BPLG, Inactivated
- Clostridium perfringens, type A, alpha toxoid
- Clostridium novyi, type B, toxoid
- Clostridium septicum, toxoid
- Clostridium tetani, toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type D, epsilon toxoid
- Clostridium chauvoei, strain 3796, Inactivated
- Clostridium chauvoei, strain P459, Inactivated
Identifikazzjoni tal-prodott
Isem tal-mediċina:
TASVAX HUIT
Speċi li fuqhom ser jintuża l-prodott:
Metodu ta’ amministrazzjoni:
-
Użu għal taħt il-ġilda
Dettalji tal-prodott
Sustanza attiva / Qawwa:
-
Disponibbli biss fi English1.0090% protective dose in guinea pig1.00unit(s)
-
Disponibbli biss fi English1.60enzyme-linked immunosorbent assay unit1.00unit(s)
-
Disponibbli biss fi English3.90enzyme-linked immunosorbent assay unit1.00unit(s)
-
Disponibbli biss fi English4.40enzyme-linked immunosorbent assay unit1.00unit(s)
-
Disponibbli biss fi English2.30enzyme-linked immunosorbent assay unit1.00unit(s)
-
Disponibbli biss fi English13.10enzyme-linked immunosorbent assay unit1.00unit(s)
-
Disponibbli biss fi English4.00enzyme-linked immunosorbent assay unit1.00unit(s)
-
Disponibbli biss fi English1.0090% protective dose in guinea pig1.00unit(s)
-
Disponibbli biss fi English1.0090% protective dose in guinea pig1.00unit(s)
Forma farmaċewtika:
-
Suspensjoni għall-injezzjoni
Withdrawal period by route of administration:
-
Użu għal taħt il-ġilda
-
Cattle
-
All relevant tissues0day
-
-
Sheep
-
All relevant tissues0day
-
-
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
- QI02AB01
- QI04AB01
Status tal-awtorizzazzjoni:
-
Surrendered
Tagħrif addizzjonali
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
- Zoetis France
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
- Zoetis Belgium
Awtorità responsabbli:
- French Agency For Food, Environmental And Occupational Health & Safety
Numru tal-awtorizzazzjoni:
- FR/V/6594261 7/1983
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Dokumenti
Sommarju tal-karatteristiċi tal-prodott
Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
French (PDF)
Ippubblikat fuq: 4/04/2022
Kemm kienet utli din il-paġna?: